A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study.
Explore the source record for details and available documents.
Aged↗
Biomedical subjects
R Blacklock
Publications and source records attributed to R Blacklock.
Training in urology.
Explore the source record for details and available documents.
Education, Medical, Graduate↗